Sufentanil Used by Paramedics to Treat Pain in Acute Trauma
The Safety of Administration of Sufentanil by Paramedics to Treat Pain in Acute Trauma in The Prehospital Setting: Observational Study
1 other identifier
observational
158
1 country
1
Brief Summary
The new competence of paramedics to administer opioid analgesics in acute trauma patients without presence or phone-call consult with an emergency medical doctor will be assessed in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2021
CompletedFirst Submitted
Initial submission to the registry
May 17, 2021
CompletedFirst Posted
Study publicly available on registry
June 4, 2021
CompletedJune 4, 2021
May 1, 2021
6 months
May 17, 2021
May 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of apnea
Measurement of incidence of adverse effects of sufentanil administration in both study groups - apnea - during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).
After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.
The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of bradypnoea
Measurement of incidence of adverse effects of sufentanil administration in both study groups - bradypnoea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).
After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.
The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of nausea.
Measurement of incidence of adverse effects of sufentanil administration in both study groups - nausea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).
After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.
The safety of pain treatment by the paramedics with competence to sufentanil administration in acute trauma - incidence of bradypnoea.
Measurement of incidence of adverse effects of sufentanil administration in both study groups - vomiting - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).
After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.
The efficacy of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - visual analogue scale.
The ten point Visual analogue scale is used to measure the efficacy of pain treatment. The difference of VAS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).
Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.
The efficacy of pain treatment by the paramedics with competence to sufentanil -administration in acute trauma - numeric rating scale.
The ten point Numeric rating scale (NRS) is used to measure the efficacy of pain treatment. The difference of NRS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).
Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.
Secondary Outcomes (8)
Dose of administered sufentanil
After sufentanil administration, up to 60 minutes.
Incidence of potentiation of analgesia by other analgesics
After sufentanil administration, up to 60 minutes.
Types of drugs used for potentiation of analgesia by sufentanil
After sufentanil administration, up to 60 minutes.
The influence on haemodynamic parameters - non invasive blood pressure (BP) -systolic blood pressure
Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.
The influence on haemodynamic parameters - non invasive blood pressure (BP) - diastolic blood pressure
Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.
- +3 more secondary outcomes
Study Arms (2)
Consultation
Patient who were administered sufentanil in acute trauma by paramedics after phone call consultation with medical doctor.
Competency
Patient who were administered sufentanil in acute trauma by paramedics with competence to administer sufentanil without any consultation with medical doctor.
Interventions
Administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.
Administration of sufentanil to patients with acute injury by paramedics with competency to administer sufentanil without medical doctor consultation.
Eligibility Criteria
Adults patient in prehospital emergency care, who suffered acute trauma with severe pain.
You may qualify if:
- acute trauma with severe pain (VAS/NRS \> 4)
- age \> 18 years
- conscious patient (GCS = 15; alert in AVPU)
- haemodynamically stable patient (\> 100mmHg of systolic blood pressure, \> 60/min of heart rate)
You may not qualify if:
- doctor on site
- paediatric patient
- predominantly chronic but not acute pain
- incomplete documentation
- other than traumatic reasons for opioid administration (eg. acute coronary syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zdravotnická záchranná služba Karlovarského kraje, p.o.
Karlovy Vary, Karlovarský kraj, 360 06, Czechia
Related Publications (2)
Gnirke A, Beckers SK, Gort S, Sommer A, Schroder H, Rossaint R, Felzen M. [Analgesia in the emergency medical service: comparison between tele-emergency physician and call back procedure with respect to application safety, effectiveness and tolerance]. Anaesthesist. 2019 Oct;68(10):665-675. doi: 10.1007/s00101-019-00661-0. Epub 2019 Sep 5. German.
PMID: 31489458BACKGROUNDScharonow M, Alberding T, Oltmanns W, Weilbach C. Project for the introduction of prehospital analgesia with fentanyl and morphine administered by specially trained paramedics in a rural service area in Germany. J Pain Res. 2017 Nov 6;10:2595-2599. doi: 10.2147/JPR.S151077. eCollection 2017.
PMID: 29158691RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roman SYKORA, PhD
Emergency Medical Service of Karlovy Vary Region, Czech Republic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research coordinator
Study Record Dates
First Submitted
May 17, 2021
First Posted
June 4, 2021
Study Start
September 14, 2020
Primary Completion
March 23, 2021
Study Completion
May 15, 2021
Last Updated
June 4, 2021
Record last verified: 2021-05